 Limited logo1.jpg){kind=logo}
Share the post "Natural Biocon (India) ‘s Q1 Update: Profit Grows by 100% YoY"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 264.21 % in the past year, decrease in net sales/revenue by -91.32 %.
- Profit over the Year and quarter: Significant improvement in profitability for Natural Biocon (India) Limited. Notable increase of 81.48 % in net profit Year to Year, Natural Biocon (India) Limited’s profitability increased by 66.1 % in this quarter.
- EPS over the Year and quarter: EPS increased by 0 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0.271 Cr | Rs. 11.37 Cr | Rs. 0.987 Cr | -91.32 % | + 264.21 % |
| Expenses | Rs. 0.22 Cr | Rs. 11.24 Cr | Rs. 0.89 Cr | -92.08 % | + 304.55 % |
| Operating Profit | Rs. 0.05 Cr | Rs. 0.13 Cr | Rs. 0.1 Cr | -23.08 % | + 100 % |
| OPM % | 18.45 % | 1.14 % | 10.13 % | + 8.99 % | -8.32 % |
| Other Income | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Interest | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Depreciation | Rs. 0 Cr | Rs. 0 Cr | Rs. 0 Cr | 0 % | 0 % |
| Profit before tax | Rs. 0.05 Cr | Rs. 0.13 Cr | Rs. 0.1 Cr | -23.08 % | + 100 % |
| Tax % | 0 % | 55.73 % | 0 % | -55.73 % | 0 % |
| Net Profit | Rs. 0.05 Cr | Rs. 0.06 Cr | Rs. 0.1 Cr | + 66.67 % | + 100 % |
| EPS in Rs | Rs. 0 | Rs. 0.01 | Rs. 0.01 | + 0 % | 0 % |
Today, we’re looking at Natural Biocon (India) Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 264.21 %. However, it did see a marginal slip of -91.32 % from the previous quarter. Expenses decreased slightly by -92.08 % quarter-on-quarter, aligning with the annual rise of 304.55 %. Operating profit, while up 100 % compared to last year, faced a quarter-on-quarter dip of -23.08 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -8.32 %, but an expansion of 8.99 % sequentially. Profit before tax grew annually by 100 % but saw a reduction from the preceding quarter by -23.08 %.
with a more notable quarter-on-quarter decrease of -55.73 %. Net profit rose by 100 % year-on-year but experienced a 66.67 % expansion from the last quarter. but a quarterly rise of 0 %. In summary, Natural Biocon (India) Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 0.271 Cr | Rs. 11.37 Cr | Rs. 0.987 Cr | -91.32 % | + 264.21 % |
| Expenses | Rs. 0.22 Cr | Rs. 11.24 Cr | Rs. 0.89 Cr | -92.08 % | + 304.55 % |
| Operating Profit | Rs. 0.05 Cr | Rs. 0.13 Cr | Rs. 0.1 Cr | -23.08 % | + 100 % |
| Net Profit | Rs. 0.05 Cr | Rs. 0.06 Cr | Rs. 0.1 Cr | + 66.67 % | + 100 % |
| EPS in Rs | Rs. 0 | Rs. 0.01 | Rs. 0.01 | + 0 % | 0 % |
In reviewing Natural Biocon (India) Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 264.21 % year-on-year growth, although there was a slight dip of -91.32 % from the previous quarter. Expenses rose by 304.55 % compared to the previous year, with a decrease of -92.08 % quarter-on-quarter. Operating Profit surged by 100 % annually, and saw a -23.08 % decrease from the last quarter.
Net Profit showed yearly increase of 100 %, and experienced a 66.67 % increase from the previous quarter. however rose by 0 % compared to the last quarter. In essence, while Natural Biocon (India) Limited faces strong annual decline indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
54
3-Year Profit
42
5-Year Profit
51
10-Year Profit
157
Current Price
3,820
Market Cap
Upon examining the financial data for BSE code 532406, it becomes clear that the company achieved a notable five-year profit of 42 percents, which impressively increased to 54 percents in the three-year window. This upward trajectory, however, has been overshadowed by the latest trailing twelve-month (TTM) figures, which indicate a concerning loss of 42 percents. This financial loss is further compounded by the fact that the company has not recorded any sales across any of the timeframes under consideration. Such an unusual situation might suggest that the company operates under an unconventional business model, which could potentially carry higher risks. In terms of stock performance, the company’s stock price has seen a decline, falling from 112 percents over the five-year period to just 47 percents in the last year. The ten-year average stock price, which sits at 49 percents, highlights long-term volatility, casting doubt on the company's ability to sustain its market position over time. This warrants further investigation into the factors driving these fluctuations.
Currently valued at ₹3,820 crore, the company's stock price stands at ₹157. Over the years, it has seen significant fluctuations, with its price ranging from ₹224 / 86.0, a reflection of its sensitivity to market conditions and investor sentiment. The stock's Price-to-Earnings (P/E) ratio, currently at 65.0, suggests that it is highly valued in comparison to its earnings, possibly indicating strong future growth expectations or a high level of investor confidence. The book value per share is ₹8.09, which represents the net asset value of the company per share. The dividend yield of 0.12% provides some return to investors, though it may not be the primary attraction for those investing in the stock. The company's Return on Capital Employed (ROCE) is 47.4%, pointing to efficient use of its capital base to generate profits. The Return on Equity (ROE), at 38.7%, highlights the profitability for shareholders. The company's financial health is further underscored by its very low debt-to-equity ratio of 0.09, signaling conservative financial management. However, the net cash flow is negative at ₹0.86 crore, indicating possible liquidity concerns or heavy investment. The Piotroski score of 8.00 provides a snapshot of its financial stability, while the Graham Number, estimated at ₹21.0, offers an intrinsic value benchmark. With a Price-to-Book (P/B) ratio of 19.4, the stock seems to be trading at a premium relative to its book value, which could signal strong market expectations or overvaluation risks.
![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/shareholding/credits-wion-6-1.png)
